MLPS represent approximately 20–30% of the liposarcoma subfamily and are defined by the fusion oncogene FUS-DDIT3 resulting from the genetic translocation t(12:16)(q13:p11) or less frequently EWSR1-DDIT3 resulting from t(12;22)(q13;q12)58. This evidence concerns the gene DDIT3 and liposarcoma.